Literature DB >> 31208240

How glycogen sustains brain function: A plausible allosteric signaling pathway mediated by glucose phosphates.

Mauro DiNuzzo1.   

Abstract

Astrocytic glycogen is the sole glucose reserve of the brain. Both glycogen and glucose are necessary for basic neurophysiology and in turn for higher brain functions. In spite of low concentration, turnover and stimulation-induced degradation, any interference with normal glycogen metabolism in the brain severely affects neuronal excitability and disrupts memory formation. Here, I briefly discuss the glycogenolysis-induced glucose-sparing effect, which involves glucose phosphates as key allosteric effectors in the modulation of astrocytic and neuronal glucose uptake and phosphorylation. I further advance a novel and thus far unexplored effect of glycogenolysis that might be mediated by glucose phosphates.

Entities:  

Keywords:  Energy metabolism; astrocytes; glucose; metabolism; neuronal-glial interaction

Mesh:

Substances:

Year:  2019        PMID: 31208240      PMCID: PMC6681540          DOI: 10.1177/0271678X19856713

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  95 in total

1.  Hexokinase in astrocytes: kinetic and regulatory properties.

Authors:  J C Lai; K L Behar; B B Liang; L Hertz
Journal:  Metab Brain Dis       Date:  1999-06       Impact factor: 3.584

Review 2.  An energy budget for signaling in the grey matter of the brain.

Authors:  D Attwell; S B Laughlin
Journal:  J Cereb Blood Flow Metab       Date:  2001-10       Impact factor: 6.200

3.  FXYD7 is a brain-specific regulator of Na,K-ATPase alpha 1-beta isozymes.

Authors:  Pascal Béguin; Gilles Crambert; Florianne Monnet-Tschudi; Marc Uldry; Jean-Daniel Horisberger; Haim Garty; Käthi Geering
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

4.  Transport and pharmacological properties of nine different human Na, K-ATPase isozymes.

Authors:  G Crambert; U Hasler; A T Beggah; C Yu; N N Modyanov; J D Horisberger; L Lelièvre; K Geering
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

5.  Glycolysis and glutamate accumulation into synaptic vesicles. Role of glyceraldehyde phosphate dehydrogenase and 3-phosphoglycerate kinase.

Authors:  Atsushi Ikemoto; David G Bole; Tetsufumi Ueda
Journal:  J Biol Chem       Date:  2002-12-17       Impact factor: 5.157

6.  Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake.

Authors:  Desmond G Hunt; Zhenping Ding; John L Ivy
Journal:  J Appl Physiol (1985)       Date:  2002-03

7.  Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase.

Authors:  Roger R Gomis; Emili Cid; Mar García-Rocha; Juan C Ferrer; Joan J Guinovart
Journal:  J Biol Chem       Date:  2002-03-06       Impact factor: 5.157

8.  Negligible glucose-6-phosphatase activity in cultured astroglia.

Authors:  J Gotoh; Y Itoh; T Y Kuang; M Cook; M J Law; L Sokoloff
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

9.  Dual mechanisms for glucose 6-phosphate inhibition of human brain hexokinase.

Authors:  X Liu; C S Kim; F T Kurbanov; R B Honzatko; H J Fromm
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

10.  The effect of galactose metabolic disorders on rat brain Na+,K+-ATPase activity.

Authors:  Stylianos Tsakiris; Kyriakoula Marinou; Kleopatra H Schulpis
Journal:  Z Naturforsch C J Biosci       Date:  2002 Sep-Oct
View more
  2 in total

1.  Glucose sparing by glycogenolysis (GSG) determines the relationship between brain metabolism and neurotransmission.

Authors:  Douglas L Rothman; Gerald A Dienel; Kevin L Behar; Fahmeed Hyder; Mauro DiNuzzo; Federico Giove; Silvia Mangia
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-07       Impact factor: 6.960

Review 2.  The Role of Brain Glycogen in Supporting Physiological Function.

Authors:  Laura R Rich; William Harris; Angus M Brown
Journal:  Front Neurosci       Date:  2019-11-01       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.